$MTEX
Mannatech Inc Stock $mtex

$mtex Overview Financials Valuation SEC Filings Company Website

2018 Q2 Form 10-Q Financial Statement

#000105635818000095 Filed on August 06, 2018

Income Statement

Concept	2018 Q2	2017 Q2
Revenue	$45.14M	$47.70M
YoY Change	-5.37%	-2.25%
Cost Of Revenue	$8.141M	$8.786M
YoY Change	-7.34%	-13.01%
Gross Profit	$37.00M	$38.90M
YoY Change	-4.89%	0.49%
Gross Profit Margin	81.96%	81.55%
Selling, General & Admin	$28.90M	$29.00M
YoY Change	-0.34%	-3.65%
% of Gross Profit	78.12%	74.55%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$535.0K	$453.0K
YoY Change	18.1%	-5.03%
% of Gross Profit	1.45%	1.16%
Operating Expenses	$37.35M	$36.08M
YoY Change	3.5%	-7.06%
Operating Profit	-$349.0K	$2.819M
YoY Change	-112.38%	-2616.96%
Interest Expense	$100.0K	$0.00
YoY Change
% of Operating Profit		0.0%
Other Income/Expense, Net	$476.0K	-$9.000K
YoY Change	-5388.89%	-99.13%
Pretax Income	$260.0K	$2.829M
YoY Change	-90.81%	-351.24%
Income Tax	$644.0K	$1.034M
% Of Pretax Income	247.69%	36.55%
Net Earnings	-$384.0K	$1.795M
YoY Change	-121.39%	-234.76%
Net Earnings / Revenue	-0.85%	3.76%
Basic Earnings Per Share	-$0.14	$0.66
Diluted Earnings Per Share	-$0.14	$0.65
COMMON SHARES
Basic Shares Outstanding	2.674M shares	2.711M shares
Diluted Shares Outstanding	2.674M shares	2.778M shares

Balance Sheet

Concept	2018 Q2	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$28.80M	$35.60M
YoY Change	-19.1%	-3.52%
Cash & Equivalents	$28.78M	$35.56M
Short-Term Investments
Other Short-Term Assets	$8.100M	$7.400M
YoY Change	9.46%	-14.94%
Inventory	$10.28M	$10.87M
Prepaid Expenses
Receivables	$237.0K	$405.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$47.41M	$54.24M
YoY Change	-12.6%	-5.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.500M	$4.500M
YoY Change	44.44%	-13.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.827M	$3.617M
YoY Change	5.81%	-74.71%
Total Long-Term Assets	$23.23M	$20.52M
YoY Change	13.24%	5.21%
TOTAL ASSETS
Total Short-Term Assets	$47.41M	$54.24M
Total Long-Term Assets	$23.23M	$20.52M
Total Assets	$70.64M	$74.76M
YoY Change	-5.51%	-2.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.414M	$6.130M
YoY Change	4.63%	-4.22%
Accrued Expenses	$6.331M	$5.139M
YoY Change	23.2%	-4.83%
Deferred Revenue	$7.287M
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.100M	$1.200M
YoY Change	-8.33%	-7.69%
Total Short-Term Liabilities	$34.54M	$32.04M
YoY Change	7.8%	-5.77%
LONG-TERM LIABILITIES
Long-Term Debt	$900.0K	$500.0K
YoY Change	80.0%	-61.54%
Other Long-Term Liabilities	$2.810M	$1.413M
YoY Change	98.87%	-32.71%
Total Long-Term Liabilities	$2.810M	$1.413M
YoY Change	98.87%	-58.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$34.54M	$32.04M
Total Long-Term Liabilities	$2.810M	$1.413M
Total Liabilities	$39.38M	$33.95M
YoY Change	16.0%	-8.99%
SHAREHOLDERS EQUITY
Retained Earnings	$2.862M	$7.202M
YoY Change	-60.26%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$9.698M	$5.166M
YoY Change	87.73%
Treasury Stock Shares	340.2K shares	42.42K shares
Shareholders Equity	$31.26M	$40.81M
YoY Change
Total Liabilities & Shareholders Equity	$70.64M	$74.76M
YoY Change	-5.51%	-2.91%

Cashflow Statement

Concept	2018 Q2	2017 Q2
OPERATING ACTIVITIES
Net Income	-$384.0K	$1.795M
YoY Change	-121.39%	-234.76%
Depreciation, Depletion And Amortization	$535.0K	$453.0K
YoY Change	18.1%	-5.03%
Cash From Operating Activities	$720.0K	$7.740M
YoY Change	-90.7%	128.32%
INVESTING ACTIVITIES
Capital Expenditures	-$790.0K	-$320.0K
YoY Change	146.88%	-54.29%
Acquisitions
YoY Change
Other Investing Activities	$60.00K	$0.00
YoY Change
Cash From Investing Activities	-$730.0K	-$320.0K
YoY Change	128.13%	-54.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-7.560M	-740.0K
YoY Change	921.62%	105.56%
NET CHANGE
Cash From Operating Activities	720.0K	7.740M
Cash From Investing Activities	-730.0K	-320.0K
Cash From Financing Activities	-7.560M	-740.0K
Net Change In Cash	-7.570M	6.680M
YoY Change	-213.32%	186.7%
FREE CASH FLOW
Cash From Operating Activities	$720.0K	$7.740M
Capital Expenditures	-$790.0K	-$320.0K
Free Cash Flow	$1.510M	$8.060M
YoY Change	-81.27%	97.07%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2706000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2696000	shares
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	mtex	Sales Revenue Goods Percentage SalesRevenueGoodsPercentage	1.000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
	dei	Document Period End Date DocumentPeriodEndDate	2018-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001056358
CY2018Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2402612	shares
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Registrant Name EntityRegistrantName	MANNATECH INC
CY2017Q4	mtex	Accrued Lease Restoration Costs AccruedLeaseRestorationCosts	400000	USD
CY2018Q2	mtex	Accrued Lease Restoration Costs AccruedLeaseRestorationCosts	400000	USD
CY2017Q2	mtex	Average Share Price AverageSharePrice	15.04
	mtex	Average Share Price AverageSharePrice	16.71
CY2018Q2	mtex	Average Share Price AverageSharePrice	19.46
	mtex	Average Share Price AverageSharePrice	17.12
CY2017Q4	mtex	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	3880000	USD
CY2018Q2	mtex	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	3124000	USD
CY2017Q2	mtex	Commissions And Incentives Expense CommissionsAndIncentivesExpense	18994000	USD
	mtex	Commissions And Incentives Expense CommissionsAndIncentivesExpense	36075000	USD
CY2018Q2	mtex	Commissions And Incentives Expense CommissionsAndIncentivesExpense	19322000	USD
	mtex	Commissions And Incentives Expense CommissionsAndIncentivesExpense	36307000	USD
CY2017Q4	mtex	Commissions And Incentives Payable CommissionsAndIncentivesPayable	9658000	USD
CY2018Q2	mtex	Commissions And Incentives Payable CommissionsAndIncentivesPayable	10090000	USD
CY2017	mtex	Customer Contract Loyalty Points Forfeited CustomerContractLoyaltyPointsForfeited	5895000	USD
	mtex	Customer Contract Loyalty Points Forfeited CustomerContractLoyaltyPointsForfeited	2131000	USD
CY2017	mtex	Customer Contract Loyalty Points Vested CustomerContractLoyaltyPointsVested	17836000	USD
	mtex	Customer Contract Loyalty Points Vested CustomerContractLoyaltyPointsVested	6345000	USD
CY2017	mtex	Customer Contracts Loyalty Points Used CustomerContractsLoyaltyPointsUsed	14316000	USD
	mtex	Customer Contracts Loyalty Points Used CustomerContractsLoyaltyPointsUsed	6754000	USD
CY2017	mtex	Customer Loyalty Points Unvested CustomerLoyaltyPointsUnvested	1748000	USD
	mtex	Customer Loyalty Points Unvested CustomerLoyaltyPointsUnvested	1091000	USD
CY2016Q4	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	7033000	USD
CY2017Q4	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	6406000	USD
CY2017Q4	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	6400000	USD
CY2018Q2	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	4957000	USD
CY2018Q2	mtex	Customer Loyalty Program Contract Liability Current CustomerLoyaltyProgramContractLiabilityCurrent	5000000	USD
	mtex	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	-51000	USD
	mtex	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	-756000	USD
	mtex	Increase Decrease In Commissions And Incentives Payable IncreaseDecreaseInCommissionsAndIncentivesPayable	730000	USD
	mtex	Increase Decrease In Commissions And Incentives Payable IncreaseDecreaseInCommissionsAndIncentivesPayable	432000	USD
	mtex	Interest Paid On Capital Leases And Financing Arrangements InterestPaidOnCapitalLeasesAndFinancingArrangements	37000	USD
	mtex	Interest Paid On Capital Leases And Financing Arrangements InterestPaidOnCapitalLeasesAndFinancingArrangements	23000	USD
	mtex	Number Of Countries In Which Entity Network Marketing And Distribution Channels Operates NumberOfCountriesInWhichEntityNetworkMarketingAndDistributionChannelsOperates	25	country
	mtex	Number Of Countries In Which Entity Sells Products NumberOfCountriesInWhichEntitySellsProducts	26	country
	mtex	Number Of Regions In Which Company Sells Products NumberOfRegionsInWhichCompanySellsProducts	3	region
	mtex	Percentage Of Sale Returns PercentageOfSaleReturns	0.015
CY2017Q4	mtex	Property Plant And Equipment Net Excluding Construction In Progress PropertyPlantAndEquipmentNetExcludingConstructionInProgress	3537000	USD
CY2018Q2	mtex	Property Plant And Equipment Net Excluding Construction In Progress PropertyPlantAndEquipmentNetExcludingConstructionInProgress	5656000	USD
	mtex	Revenue Number Of Performance Obligations Online Business Tools RevenueNumberOfPerformanceObligationsOnlineBusinessTools	3	performance_obligation
	mtex	Revenue Number Of Performance Obligations Product Sales RevenueNumberOfPerformanceObligationsProductSales	2	performance_obligation
	mtex	Revenue Performance Obligations Term Of Services Online Business Tools RevenuePerformanceObligationsTermOfServicesOnlineBusinessTools	P3M
CY2017Q2	mtex	Sales Revenue Goods Percentage SalesRevenueGoodsPercentage	1.000
CY2018Q2	mtex	Sales Revenue Goods Percentage SalesRevenueGoodsPercentage	1.000
	mtex	Sales Revenue Goods Percentage SalesRevenueGoodsPercentage	1.000
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6008000	USD
CY2018Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	6414000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	273000	USD
CY2018Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	237000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5771000	USD
CY2018Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6331000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5984000	USD
CY2018Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4292000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	34928000	USD
CY2018Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33806000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	626000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	600000	USD
CY2018Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	600000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	582000	USD
CY2018Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	636000	USD
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	300000	shares
CY2018Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	300000	shares
CY2017Q4	us-gaap	Assets Assets	76242000	USD
CY2018Q2	us-gaap	Assets Assets	70640000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	56248000	USD
CY2018Q2	us-gaap	Assets Current AssetsCurrent	47408000	USD
CY2017Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	228000	USD
CY2018Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	98000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	130000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	2281000	USD
CY2017Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	144000	USD
CY2018Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	108000	USD
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1800000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28687000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37682000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28775000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36626000	USD
CY2017Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43851000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46761000	USD
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37530000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7225000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9231000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.125
CY2018Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.125
CY2018Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.125
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	99000000	shares
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	99000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2742857	shares
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2742857	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2702940	shares
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2402612	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1064000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2196000	USD
CY2018Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2410000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2340000	USD
CY2017Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	777000	USD
CY2018Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	873000	USD
CY2017Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8561000	USD
CY2018Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7287000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4600000	USD
CY2017Q2	us-gaap	Cost Of Revenue CostOfRevenue	8786000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	17548000	USD
CY2018Q2	us-gaap	Cost Of Revenue CostOfRevenue	8141000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	16390000	USD
CY2017Q4	us-gaap	Credit Card Receivables CreditCardReceivables	2000000	USD
CY2018Q2	us-gaap	Credit Card Receivables CreditCardReceivables	2100000	USD
CY2017Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4239000	USD
CY2018Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5634000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-191000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1444000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1147000	USD
CY2018Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1098000	USD
CY2018Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1400000	USD
CY2017Q4	us-gaap	Deposit Assets DepositAssets	1700000	USD
CY2018Q2	us-gaap	Deposit Assets DepositAssets	1700000	USD
CY2017Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	453000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	955000	USD
CY2018Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	535000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1046000	USD
CY2018Q1	us-gaap	Dividends Dividends	340000	USD
CY2018Q2	us-gaap	Dividends Dividends	340000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	680000	USD
CY2017Q4	us-gaap	Due From Banks DueFromBanks	30600000	USD
CY2018Q2	us-gaap	Due From Banks DueFromBanks	18300000	USD
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.66
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.65
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1510000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1660000	USD
CY2017Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.365
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.366
CY2018Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-3.598
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.446
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9978000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18632000	USD
CY2018Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9615000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17595000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	38900000	USD
	us-gaap	Gross Profit GrossProfit	70779000	USD
CY2018Q2	us-gaap	Gross Profit GrossProfit	36996000	USD
	us-gaap	Gross Profit GrossProfit	70130000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2829000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	865000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	260000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-311000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1034000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	317000	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	644000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	337000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	479000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	273000	USD
CY2017Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	907000	USD
CY2018Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	882000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	406000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	169000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	180000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	493000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	891000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-701000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	749000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	57000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1274000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1590000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-907000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1155000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1231000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-561000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-50000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1207000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	188000	USD
CY2017Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	200000	USD
CY2018Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	200000	USD
CY2017Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	19000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	48000	USD
CY2018Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	133000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	162000	USD
CY2017Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	9072000	USD
CY2018Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	10354000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	9400000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	9385000	USD
CY2018Q2	us-gaap	Inventory Net InventoryNet	10300000	USD
CY2018Q2	us-gaap	Inventory Net InventoryNet	10277000	USD
CY2017Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	879000	USD
CY2018Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	485000	USD
CY2017Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	566000	USD
CY2018Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	562000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	202000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	339000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	36001000	USD
CY2018Q2	us-gaap	Liabilities Liabilities	39378000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	76242000	USD
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	70640000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	33445000	USD
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	34535000	USD
CY2017Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	200000	USD
CY2018Q2	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	200000	USD
CY2017Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	USD
CY2018Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	827000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1436000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8257000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-680000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1012000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7831000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1698000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	1795000	USD
	us-gaap	Net Income Loss NetIncomeLoss	548000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-384000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-648000	USD
CY2017Q4	us-gaap	Noncurrent Assets NoncurrentAssets	4300000	USD
CY2018Q2	us-gaap	Noncurrent Assets NoncurrentAssets	6500000	USD
CY2017Q4	us-gaap	Notes Payable NotesPayable	800000	USD
CY2018Q2	us-gaap	Notes Payable NotesPayable	1800000	USD
CY2017Q4	us-gaap	Notes Payable Current NotesPayableCurrent	815000	USD
CY2017Q4	us-gaap	Notes Payable Current NotesPayableCurrent	800000	USD
CY2018Q2	us-gaap	Notes Payable Current NotesPayableCurrent	1019000	USD
CY2018Q2	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	14	country
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	36081000	USD
	us-gaap	Operating Expenses OperatingExpenses	69994000	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	37345000	USD
	us-gaap	Operating Expenses OperatingExpenses	71367000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	2819000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	785000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-349000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1237000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3876000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3900000	USD
CY2018Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3827000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-731000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1648000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2026000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1692000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1692000	USD
CY2017Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	6656000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	14332000	USD
CY2018Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	7873000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	16419000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1265000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1300000	USD
CY2018Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2810000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	32000	USD
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	476000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	764000	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	0	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	-62000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	64000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6830000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	677000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	680000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	680000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1074000	USD
CY2017Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent	400000	USD
CY2018Q2	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent	400000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2018Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	83000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2775000	shares
CY2018Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2607000	USD
CY2018Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3482000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	73000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	216000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2696000	shares
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	778000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	747000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	9100000	USD
CY2018Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	8800000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1514000	USD
CY2018Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1513000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7565000	USD
CY2018Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7242000	USD
CY2016Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1510000	USD
CY2017Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1514000	USD
CY2018Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	1513000	USD
CY2016Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6429000	USD
CY2017Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	7565000	USD
CY2018Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	7242000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4190000	USD
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2862000	USD
CY2018Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	16000000	USD
CY2018Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	6800000	USD
CY2018Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	316659	shares
CY2018Q2	us-gaap	Sale Of Stock Percentage Of Ownership After Transaction SaleOfStockPercentageOfOwnershipAfterTransaction	0.116
CY2018Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	21.00
CY2017Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	47686000	USD
CY2017Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	47700000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	88327000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	88300000	USD
CY2018Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	45100000	USD
CY2018Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	45137000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	86520000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	86500000	USD
CY2017Q4	us-gaap	Security Deposit SecurityDeposit	1900000	USD
CY2018Q2	us-gaap	Security Deposit SecurityDeposit	1900000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	388000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	871000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	250000	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	39572	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	184667	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.87
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.29
	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	245000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	40241000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	31262000	USD
CY2017Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2404000	USD
CY2018Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	3296000	USD
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	39917	shares
CY2018Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	340245	shares
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	4861000	USD
CY2018Q2	us-gaap	Treasury Stock Value TreasuryStockValue	9698000	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	6830000	USD
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2778000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2674000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2674000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2711000	shares
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LITIGATION</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Insured Litigation - Personal Injury</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Ralph Pinkston v. Cornerstone Technologies, LLC d/b/a Cornerstone Show Foundation, Mannatech Inc., and Anatole Partners III, LLC</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">, Case No. DC-17-13494 (192nd Dist. Ct., Dallas, Co., Tex)</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 13, 2017, the Company’s registered agent received service of process of the above-captioned matter. Ralph Pinkston (the “Plaintiff”) is a truck driver who is alleging that he suffered injuries to his foot while unloading audio-visual equipment owned by Defendant Cornerstone from his truck on to the dock at Defendant Anatole’s hotel (the “Hotel”) on the morning of April 5, 2016. The Company held its 2016 MannaFest event at the Hotel from April 6, 2016 to April 10, 2016. Defendant Cornerstone provided production services to the Company for the event. The Plaintiff alleges that his injuries were due to the negligence of the Company and the other defendants. The Plaintiff is seeking damages in excess of </font><font style="font-family:inherit;font-size:10pt;">$200,000</font><font style="font-family:inherit;font-size:10pt;">. The Company submitted this matter to its insurance carrier and retained approved outside counsel. The Plaintiff deposed </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> Company employees on May 31, 2018. The parties reached a settlement agreement on June 12, 2018 with the Company paying Plaintiff </font><font style="font-family:inherit;font-size:10pt;">$16,000</font><font style="font-family:inherit;font-size:10pt;"> in exchange for his full release of all claims against the Company. On June 21, 2018, the Court issued an Order Granting Plaintiff’s Notice of Nonsuit with Prejudice of Defendant Mannatech, Inc. The Company considers this matter closed.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Administrative Proceeding</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Mannatech Korea, Ltd. v. Busan Custom Office</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">, Busan District Court, Korea</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On or before April 12, 2015, Mannatech Korea, Ltd. filed a suit against the Busan Custom Office (“BCO”) to challenge BCO’s method of calculation regarding its assessment notice issued on July 11, 2013. The assessment notice included an audit of the Company’s imported goods covering fiscal years 2008 through 2012 and required the Company to pay </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> for this assessment, all of which was paid in January 2014. Both parties submitted a response to the Court’s inquiry on January 15, 2016. The final hearing for the case was held on May 26, 2016 where each party presented their respective arguments. The Court set the decision hearing on October 27, 2016, and the Court decided the case in the Company’s favor. However, on November 18, 2016, BCO filed an appeal to the Busan High Court. The first hearing occurred on March 31, 2017, and the second hearing occurred on April 21, 2017. The final hearing was held on June 2, 2017. The Court issued its decision on June 30, 2017 in favor of the BCO. The Company appealed this decision on August 24, 2017. The Company anticipates a final decision on the appeal by the first quarter of 2019. This matter remains open.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Patent Litigation</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Mannatech, Incorporated v. Wellness Quest, LLC and Harley Reginald McDaniel, Case No. 3:14-cv-2497, U.S. District Court, for the Northern District of Texas, Dallas Division</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 11, 2014 the Company filed a patent infringement lawsuit against Wellness Quest, LLC and Dr. H. Reginald McDaniel (“Defendants”) alleging the Defendants infringe United States Patent Nos. 7,157,431 and 7,202,220, both entitled “Compositions of Plant Carbohydrates as Dietary Supplements,” (the “Patents”) and seeking to stop their manufacture, offer, and sale of infringing glyconutritional dietary supplement products. Mediation on this matter was held on April 24, 2015 and a settlement was not reached.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 5, 2015, the Court issued an Order accepting Defendant’s stipulation of infringement under the Court’s claim interpretation and granted the Company’s partial motion for summary judgment and issued a permanent injunction against Defendants’ infringement of the Patents. The Court stayed the permanent injunction until the conclusion of Defendants’ appeal to the U.S. Court of Appeals for the Federal Circuit (the “Court of Appeals”). On August 5, 2016, the Court of Appeals issued a </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">per curium</font><font style="font-family:inherit;font-size:10pt;"> opinion affirming the trial court’s judgment in favor of the Company. On August 10, 2016, the Company filed a motion to lift the stay of permanent injunction previously issued by the trial court. On August 24, 2016, the Company received confirmation from its counsel that Defendants changed the formulation of the infringing product to a formulation proposed by the Company. On October 18, 2016, the Court entered an order lifting the stay and putting the permanent injunction back into full effect. On March 31, 2017, the Court entered the Agreed Scheduling Order for trial on damages and determination of willfulness.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 22, 2017, bankruptcy counsel for Defendant Dr. McDaniel filed a Suggestion of Bankruptcy with the Court notifying the Court and the Company that on June 20, 2017, Defendant Dr. McDaniel filed a Chapter 7 Bankruptcy in the United States Bankruptcy Court for the Northern District of Texas in Cause No. 17-42560. This case was automatically stayed, which under the Bankruptcy Code, prevents any type of collection to continue including litigation against the debtor. Defendant Dr. McDaniel asserted that the stay included Defendant Wellness Quest as it is wholly owned by Defendant Dr. McDaniel. On May 11, 2018, the Court entered an order granting a discharge to Defendant Dr. McDaniel in the bankruptcy proceeding. Concerned that the cost of prosecuting its remaining claim for damages against Defendant Wellness Quest would far exceed Defendant Wellness Quest’s ability to pay, the Company submitted an Agreed Order to Dismiss the matter on June 8, 2018. The Court entered an order dismissing the case on June 18, 2018. The Company considers this matter closed.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">In Re: Harley Reginald McDaniel, Case No. 17-42560 (U.S. Bankruptcy Court for the Northern District of Texas)</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 22, 2017, the Company received notice that on June 20, 2017, Dr. H. Reginald McDaniel (the “Debtor”) filed a Chapter 7 Bankruptcy in the United States Bankruptcy Court for the Northern District of Texas. The Company is the largest creditor based on the Company’s judgment against the Debtor in the patent litigation styled, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Mannatech, Incorporated v. Wellness Quest, LLC and Harley Reginald McDaniel</font><font style="font-family:inherit;font-size:10pt;">. The Debtor asserts that the value of the debt is </font><font style="font-family:inherit;font-size:10pt;">$700,000</font><font style="font-family:inherit;font-size:10pt;">. The Company engaged bankruptcy counsel. The first meeting of creditors was held on August 8, 2017. On August 24, 2017, the Chapter 7 Trustee and the Company each filed objections to certain exemptions asserted by the Debtor. On August 25, 2017, the U.S. Trustee filed a motion seeking dismissal of the case. On September 14, 2017, the Company filed its response opposing the U.S. Trustee’s motion on the grounds that dismissal would be contrary to the best interests of the creditors. A hearing on the motion to dismiss was held on September 20, 2017. On October 12, 2017, the U.S. Trustee stipulated to dismiss its dismissal motion. On November 7, 2017, the Company filed a proof of claim in the amount of </font><font style="font-family:inherit;font-size:10pt;">$700,000</font><font style="font-family:inherit;font-size:10pt;">. On November 27, 2017, the Company commenced an adversary proceeding in the case styled </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Mannatech, Inc. v. Harley Reginald McDaniel, Sr.</font><font style="font-family:inherit;font-size:10pt;">, Adversary Number 17-04153 against the Debtor seeking a declaration that the indebtedness to Mannatech is non-dischargeable. On December 27, 2017, the Chapter 7 Trustee, the Debtor, and the Company negotiated a Settlement and Compromise Agreement and on January 2, 2018, the Chapter 7 Trustee filed a motion seeking the Court’s approval of that agreement. On January 31, 2018, the Court entered an Order granting the Trustee’s motion. On March 9, 2018, the Company dismissed the adversarial case against the Debtor. On March 15, 2018, the Company received notice that the Chapter 7 Trustee submitted the Final Report to the U.S. Trustee’s office for approval. The U.S. Trustee filed the Notice of the Trustee’s Final Report and Application for Compensation with the Court on April 24, 2018. Under the Final Report, the Company is scheduled to receive </font><font style="font-family:inherit;font-size:10pt;">$62,976.69</font><font style="font-family:inherit;font-size:10pt;"> for its allowed, general unsecured claim. Objections to the Final Report or the Application for Compensation must be filed with Court and served on the U.S. Trustee within </font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;"> days of the date of the notice. If no objection to the Final Report is filed and served, the U.S. Trustee may pay proceeds contemplated by the Final Report without further order of the Court. No objections to the Final Report were filed. On May 11, 2018, the Court entered an order granting a discharge to the Debtor. On June 4, 2018 the Company received a check for $62,976.69 as its portion of the proceeds from the bankruptcy estate. The Company considers this matter closed.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Trademark Opposition - U.S. Patent and Trademark Office</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">United States Trademark Opposition No. 91221493, Shaklee Corporation v. Mannatech, Incorporated re: UTH</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 15, 2015, the Company received notice that Shaklee Corporation (“Shaklee”) filed a Notice of Opposition to the Company’s trademark application for UTH (stylized as Û </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">th</sup></font><font style="font-family:inherit;font-size:10pt;">) with the USPTO. On May 19, 2015, the Company filed an answer to the opposition and also filed a counterclaim seeking to cancel Shaklee’s registration of its YOUTH mark. </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 28, 2017, the Trademark Trial and Appeal Board (the "TTAB") ruled on the 56(d) Motion, granting the Company’s motion in part to oblige Shaklee to answer the Company’s request for discovery related to Shaklee’s use or non-use of the YOUTH mark. The Company took the deposition of Shaklee’s designated witness on May 31, 2017. On June 29, 2017, the Company filed Applicant’s Opposition to Opposer’s Motion for Summary Judgment on Applicant’s Counterclaim for Abandonment and Applicant’s Cross Motion for Summary Judgment on its Counterclaim for Abandonment. Shaklee’s reply in support of their Motion for Summary Judgement and Response to the Company’s Counterclaim was filed on August 3, 2017. Each party’s respective motions for summary judgment were denied by the TTAB. The Company filed its expert disclosures on and the parties completed discovery on May 21, 2018. The Company’s pretrial disclosures are due on September 3, 2018. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">It is not possible at this time to predict the outcome of this office action or whether the Company will incur any liability, or to estimate the ranges of damages, if any, which may be incurred in connection with this matter. However, the Company believes it has a valid defense and will vigorously defend this claim. This matter remains open.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Litigation in</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">General</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has incurred several claims in the normal course of business. The Company believes such claims can be resolved without any material adverse effect on its consolidated financial position, results of operations, or cash flows.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company maintains certain liability insurance; however, certain costs of defending lawsuits are not covered by or only partially covered by its insurance policies, including claims that are below insurance deductibles. Additionally, insurance carriers could refuse to cover certain claims, in whole or in part. The Company accrues costs to defend itself from litigation as they are incurred or as they become determinable.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The outcome of litigation is uncertain, and despite management’s views of the merits of any litigation, or the reasonableness of the Company’s estimates and reserves, the Company’s financial statements could nonetheless be materially affected by an adverse judgment. The Company believes it has adequately reserved for the contingencies arising from current legal matters where an outcome was deemed to be probable, and the loss amount could be reasonably estimated.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the Company’s consolidated financial statements in accordance with GAAP requires the use of estimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The Company continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have not varied materially from the Company’s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. However, actual results may differ from these estimates under different assumptions or conditions.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The use of estimates is pervasive throughout the consolidated financial statements, but the accounting policies and estimates considered the most significant are described in this note to the consolidated financial statements, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Organization and Summary of Significant Accounting Policies</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

Files In Submission

Name	View Source	Status
0001056358-18-000095-index-headers.html	Edgar Link	pending
0001056358-18-000095-index.html	Edgar Link	pending
0001056358-18-000095.txt	Edgar Link	pending
0001056358-18-000095-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mtex-20180630.xml	Edgar Link	completed
mtex-20180630.xsd	Edgar Link	pending
mtex-20180630_cal.xml	Edgar Link	unprocessable
mtex-20180630_def.xml	Edgar Link	unprocessable
mtex-20180630_lab.xml	Edgar Link	unprocessable
mtex-20180630_pre.xml	Edgar Link	unprocessable
mtex0630201810-q.htm	Edgar Link	pending
mtexq2201810-qexh311.htm	Edgar Link	pending
mtexq2201810-qexh312.htm	Edgar Link	pending
mtexq2201810-qexh321.htm	Edgar Link	pending
mtexq2201810-qexh322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MTEX
Mannatech Inc Stock $mtex

2018 Q2 Form 10-Q Financial Statement

#000105635818000095 Filed on August 06, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MTEX Mannatech Inc Stock $mtex

2018 Q2 Form 10-Q Financial Statement

#000105635818000095 Filed on August 06, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MTEX
Mannatech Inc Stock $mtex